(MedPage Today) -- BETHESDA, Md. — An FDA advisory committee has voted narrowly — 8 to 6 — to recommend that the agency expand the indication for the antidepressant duloxetine (Cymbalta) to treat chronic musculoskeletal pain...

Equivocal Message on Duloxetine for Pain from Panel (click here for the full article at MedPage Today)